About SuspendedLife

Bridging Todays Medicine to Tomorrows

Suspended Life’s purpose is to help people span the gap between current medical capability and the more advanced technologies that future medicine may deliver.

Management

The leadership team responsible for executive operations and strategic direction.

Leadership and executive operations.
  • Steve Garan — Co-CEO
  • Bio: Dr. Steven A. Garan is a pioneering scientist whose visionary work in aging biology, computational modeling, and cryonics has helped shape the modern discourse on human longevity. As Director of Bioinformatics at the Center for Research and Education on Aging (CREA) at the University of California, Berkeley, and a senior researcher at Lawrence Berkeley National Laboratory, Dr. Garan has led cross-disciplinary efforts to unravel the biological mechanisms of aging. His career blends science, technology, systems thinking, and public education in a way that few in the field have achieved. A trained mathematician and systems biologist, he co-developed the Automated Imaging Microscope System (AIMS) — a breakthrough in brain imaging precision — and coined the concept of Phenomics, a systems-level framework for studying aging across genetic, environmental, and temporal dimensions. Beyond academia, Dr. Garan serves as Chief Technology Officer at Suspended Life, where he advocates for scientific rigor in cryonics and biopreservation. His work continues to bridge the frontiers of AI, biology, and regenerative science, inspiring a future where aging itself becomes a manageable condition.

  • David Wanetick — Co-Chief Executive Officer
  • Bio: David Wanetick is an investment banker and patent valuation expert. He built an international executive education company and has taught courses related to Strategic Negotiations and Patent Valuation all over the world. David is the author of seven books, including The Strategic Negotiator: A Manual for Negotiating at the Elite Level, Business Model Validation, Plight of the Patentee and Solution Nation.

  • Nuno Martins — Senior Vice-President, Business Development
  • Bio: Dr Martins is a serial entrepreneur, venture investor, international keynote speaker, and a scientist. Dr Martins is the founder and CEO of several companies, being mostly well known for being the co-founder and CEO of Lux Premium, a real estate company that has more than one thousand apartments in development in Portugal. Website: http://www.luxpremium.net. As an international speaker, Dr. Martins has delivered keynote talks in several major international conferences worldwide, attended by dozens of thousands of participants. Dr Martins delivers talks around the world, including in the United States, Hungary, Serbia, Brasil, Italy, Spain, Canada, and Portugal. As an international Keynote speaker his talks cover different topics including Entrepreneurship, Venture Investment, Artificial Intelligence, Life Extension technologies, Brain Computer Interface systems. As a scientist and an innovator, Dr. Martins is interested in technological developments with potential to solve humanity’s most challenging problems in healthcare, education, work, humanity’s existential risks, among others. Dr. Martins is currently focused on developing technologies which will hopefully have a significant impact on human healthy life extension. Dr. Martins’ research work was featured in the world’s media.

  • Mark Voelker — Senior Vice-President
  • Paul Spiegel — Senior Vice-President, General Counsel
  • Briana Azevedo, J.D. — Vice-President, Associate General Counsel & Board Secretary
  • Bio: Briana Azevedo, J.D., is a California attorney who thrives at the intersection of law, ethics, and emerging technologies. As an Associate Attorney at Eclectic Law in San Francisco, she advises startups and growing companies on contracts, negotiations, and corporate governance, helping them build strong legal and ethical foundations for innovation. With a background in philosophy, Briana is deeply interested in the ethical dimensions of scientific and technological progress—particularly how forward-thinking industries like cryonics challenge our understanding of life, legacy, and human potential. She is passionate about supporting visionary organizations that push the boundaries of what’s possible while remaining grounded in thoughtful, principled decision-making.

Suspended Life is undergoing strategic rebranding to reach Silicon Valley’s growing community of innovators and futurists. Both leaders have balanced the company’s historical legacy with a forward-looking business model, seeking partnerships and awareness among those who see technology as the key to longevity. Their leadership approach reflects Suspended Life’s core values: scientific optimism, ethical stewardship, and operational transparency.

Scientific Advisory

Providing scientific guidance and strategic insight into longevity and cryonics research.

Scientific Advisory
Guidance from leading researchers and clinicians.
  • Steve Garan — Co-CEO
  • Bio: Dr. Steven A. Garan is a pioneering scientist whose visionary work in aging biology, computational modeling, and cryonics has helped shape the modern discourse on human longevity. As Director of Bioinformatics at the Center for Research and Education on Aging (CREA) at the University of California, Berkeley, and a senior researcher at Lawrence Berkeley National Laboratory, Dr. Garan has led cross-disciplinary efforts to unravel the biological mechanisms of aging. His career blends science, technology, systems thinking, and public education in a way that few in the field have achieved. A trained mathematician and systems biologist, he co-developed the Automated Imaging Microscope System (AIMS) — a breakthrough in brain imaging precision — and coined the concept of Phenomics, a systems-level framework for studying aging across genetic, environmental, and temporal dimensions. Beyond academia, Dr. Garan serves as Chief Technology Officer at Suspended Life, where he advocates for scientific rigor in cryonics and biopreservation. His work continues to bridge the frontiers of AI, biology, and regenerative science, inspiring a future where aging itself becomes a manageable condition.

  • Nuno Martins — Senior Vice-President, Business Development
  • Bio: Dr Martins is a serial entrepreneur, venture investor, international keynote speaker, and a scientist. Dr Martins is the founder and CEO of several companies, being mostly well known for being the co-founder and CEO of Lux Premium, a real estate company that has more than one thousand apartments in development in Portugal. Website: http://www.luxpremium.net. As an international speaker, Dr. Martins has delivered keynote talks in several major international conferences worldwide, attended by dozens of thousands of participants. Dr Martins delivers talks around the world, including in the United States, Hungary, Serbia, Brasil, Italy, Spain, Canada, and Portugal. As an international Keynote speaker his talks cover different topics including Entrepreneurship, Venture Investment, Artificial Intelligence, Life Extension technologies, Brain Computer Interface systems. As a scientist and an innovator, Dr. Martins is interested in technological developments with potential to solve humanity’s most challenging problems in healthcare, education, work, humanity’s existential risks, among others. Dr. Martins is currently focused on developing technologies which will hopefully have a significant impact on human healthy life extension. Dr. Martins’ research work was featured in the world’s media.

Board of Directors

Oversight, governance, and strategic vision for Suspended Life’s mission and operations.

Board of Directors
Oversight and governance.
  • Steve Garan — Co-CEO
  • Bio: Dr. Steven A. Garan is a pioneering scientist whose visionary work in aging biology, computational modeling, and cryonics has helped shape the modern discourse on human longevity. As Director of Bioinformatics at the Center for Research and Education on Aging (CREA) at the University of California, Berkeley, and a senior researcher at Lawrence Berkeley National Laboratory, Dr. Garan has led cross-disciplinary efforts to unravel the biological mechanisms of aging. His career blends science, technology, systems thinking, and public education in a way that few in the field have achieved. A trained mathematician and systems biologist, he co-developed the Automated Imaging Microscope System (AIMS) — a breakthrough in brain imaging precision — and coined the concept of Phenomics, a systems-level framework for studying aging across genetic, environmental, and temporal dimensions. Beyond academia, Dr. Garan serves as Chief Technology Officer at Suspended Life, where he advocates for scientific rigor in cryonics and biopreservation. His work continues to bridge the frontiers of AI, biology, and regenerative science, inspiring a future where aging itself becomes a manageable condition.

  • David Wanetick — Co-Chief Executive Officer
  • Bio: David Wanetick is an investment banker and patent valuation expert. He built an international executive education company and has taught courses related to Strategic Negotiations and Patent Valuation all over the world. David is the author of seven books, including The Strategic Negotiator: A Manual for Negotiating at the Elite Level, Business Model Validation, Plight of the Patentee and Solution Nation.

Our Facility

Where innovation meets preservation — Suspended Life’s facility stands as a beacon of progress in the Bay Area’s dynamic tech and biotech landscape, uniting cutting-edge science with a mission to extend the boundaries of life itself.

Facility
Operations and on-site environment.

Suspended Life’s cryonics facility is located in San Leandro, California—strategically positioned at the nexus of innovation in the San Francisco Bay Area. Surrounded by the deep-tech ecosystem of Silicon Valley, the venture capital energy of Palo Alto, and the world class academic excellence of UC Berkeley and Stanford University, our location offers unmatched access to talent, ideas, and partnerships. We are also embedded within the largest concentration of biotech and technology companies on the planet—including industry leaders such as Genentech, Gilead Sciences, Illumina, Google, Apple, Meta, and NVIDIA—enabling unique opportunities for collaboration, cross-disciplinary innovation, and rapid adoption of emerging breakthroughs.

With proximity to three major international airports—San Francisco (45 min), San Jose (40 min), and Oakland (20 min)—Suspended Life is optimized for rapid response and global patient access. Our 5,000-square-foot facility includes a cryogenic dewar hall, conference center, and a dedicated visiting and viewing room, where families can visit their loved ones. Designed with long-term operational resilience in mind, the site incorporates advanced infrastructure and contingency planning to ensure the stability of our patient care environment.

News

Hand-picked headlines and milestones from Suspended Life and the wider longevity space.

News
Latest updates and press coverage.

Cryonics Firm Eyes Future in Silicon Valley’s Tech Culture

At its San Leandro headquarters, Suspended Life, Inc. continues its pioneering work in cryonic suspension — preserving individuals at ultra-low temperatures with the belief that future medical science may one day revive them. Founded in 1972, the company has served as one of America’s earliest and most persistent voices in life extension research.

In a feature by The San Francisco Chronicle, Co-CEO Steve Garan shared their renewed vision for Suspended Life, focusing on modernising its facilities and engaging a new generation of tech enthusiasts who view science as humanity’s best hope against mortality.

Monroe described the company’s ongoing transformation as a step towards becoming “a modern cryonics facility,” while Garan emphasised the philosophy behind their mission: “We’re offering people hope — the alternative is cremation or burial, where there’s none.”

📎 Source: The San Francisco Chronicle


Cryogenics Lab Offers Frozen Second Life

Longevity investment surpasses $12.5 billion globally.
BioAge Labs announces new trial results on age-reversal pathways.
Suspended Life demonstrates next-generation cryonics processes at its San Leandro facility.

SAN LEANDRO (KPIX) — It sounds like science fiction: upon death, your body could be frozen until medical breakthroughs in the future bring you back to life. Roughly 400 Americans have chosen this option, with their bodies stored in only three cryonics facilities across the United States — including one in the East Bay operated by Suspended Life.

“This is like a hospital,” explained Steve Garan, Suspended Life’s Co-CEO, during a tour with KPIX 5 reporter Juliette Goodrich. Garan, who also serves as Director of Bioinformatics at UC Berkeley’s Center for Research and Education (CREA) and as a researcher at Lawrence Berkeley National Laboratory, describes cryonics as the science of placing humans into a low-temperature, biologically stable state immediately after clinical death.

“Think of it as a very intense intensive care unit,” he said. The facility’s “patients” are clinically dead individuals preserved in large stainless-steel containers known as dewars — vacuum flasks filled with liquid nitrogen at –196°C, capable of preserving tissue indefinitely.

Once a doctor pronounces legal death, the body’s blood is replaced with a plasma-like fluid called a cryoprotectant, preventing ice formation. “The patient is here on this table. We perfuse them and insert thermocouples so we can monitor their temperature,” Garan explained. The cooling process moves gradually from ice, to dry ice, and finally to liquid nitrogen. “You’re completely intact here,” he added. “Some have been here for 30 years, some for 15, and one is waiting to go in right now.”

Professor Hank Greely of Stanford’s Center for Law and the Biosciences remains sceptical: “I can’t say it can’t ever possibly happen, but I wouldn’t bet a dime on it.”

Among Suspended Life’s notable patients is the late Dr. Paul Segall, a lifelong cryonicist and life-extension researcher. “He wanted to stop death and live forever, but his life was cut short,” said his brother, John Segall. Biologist David Seaborg added, “It was a tragedy but kind of a new adventure for him in a way.”

Despite uncertainty, Garan remains steadfast: “I’m a scientist and I don’t do hope. I do facts.”

The full cryonic preservation process costs around $150,000, covering perfusion, storage, and long-term care. So far, five Bay Area patients have chosen this option.

📎 Source: CBS News – Cryogenics Lab Offers Frozen Second Life